VIZ ACCESS HCM - Multi-Site Registry

StatusTerminated
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial terminated Sponsor's reason: Sponsor company opted to shift design into single center investigator initiated study focus. Show 4 more changesShow less
    • Final enrollment: 17 participants — 3% of the 500 planned
    • Primary completion date changed from estimate of Dec 2028 to Sep 17, 2026
    • Site details revised at 3 of 3 sites
    • Eligibility criteria expanded, about 4 words
  2. Site details revised at 1 of 3 sitesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Trial Details
NCT Number NCT07103057
Lead Sponsor Viz.ai, Inc.
Conditions
(from sponsor)		 Hypertrophic Cardiomyopathy
Related terms Cardiomyopathy, Hypertrophic
Enrollment 17 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov